Aspirin inhibits NF-κB activity, and inhibition of the NF-κB pathway inhibits the growth of osteosarcoma and increases the sensitivity of osteosarcoma to chemotherapy in vivo and in vitro (181, 182). This evidence concerns the gene NFKB1 and osteosarcoma.